Nuclear Medicine and Biology
Volume 33, Issue 4 , Pages 495-503 , May 2006

Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors

  • Elisa García-Garayoa

      Affiliations

    • Center for Radiopharmaceutical Science, Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 56 310 28 17; fax: +41 56 31 0 28 49.
  • ,
  • Veronique Maes

      Affiliations

    • Vrije Universiteit Brussel, Department of Organic Chemistry, B-1050 Brussel, Belgium
  • ,
  • Peter Bläuenstein

      Affiliations

    • Center for Radiopharmaceutical Science, Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland
  • ,
  • Alain Blanc

      Affiliations

    • Center for Radiopharmaceutical Science, Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland
  • ,
  • Alexander Hohn

      Affiliations

    • Center for Radiopharmaceutical Science, Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland
  • ,
  • Dirk Tourwé

      Affiliations

    • Vrije Universiteit Brussel, Department of Organic Chemistry, B-1050 Brussel, Belgium
  • ,
  • P. August Schubiger

      Affiliations

    • Center for Radiopharmaceutical Science, Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland

Received 15 November 2005 ,Revised 10 January 2006 ,Accepted 12 January 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Work partly funded by the Fund for Scientific Research-Flanders (Belgium), contract No. G.0036.04.

PII: S0969-8051(06)00012-6

doi: 10.1016/j.nucmedbio.2006.01.007

Nuclear Medicine and Biology
Volume 33, Issue 4 , Pages 495-503 , May 2006